Targacept (TRGT)
News
| May 30 | 2 Pharmaceutical Companies Trading Below Net Cash - Part II |
| May 17 | TARGACEPT INC Financials |
| May 09 | $TRGT filed latest Quarterly Report http://stks.co/3kmQ by MarketBrief |
| May 09 | TARGACEPT INC Files SEC form 10-Q, Quarterly Report |
| May 03 | Targacept Inc Earnings Call scheduled for 5:00 pm ET today |
| May 03 | Listen to $TRGT Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f5M by earningscast |
| May 03 | Targacept posts smaller Q1 profit |
| May 03 | TARGACEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Fina... |
| May 03 | Targacept Reports First Quarter 2012 Financial Results Business Wire |
| May 02 | $GTXI nice move here. also watching $GNOM $ALSK $NVAX $TRGT $SQNM all have upside moves coming by Rickz |
| Apr 25 | $TRGT Cutting 46% of Workforce by Benzinga |
| Apr 23 | $TRGT i see another gap down in its future by escarleto |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Biotechnology
Targacept, Inc. is a biopharmaceutical company. It is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic receptors, or NNRs. Targacept provides treatment options for complex diseases and disorders to improve the lives of patients by developing medicines that exploit the unique role of NNRs. The company was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello in March 1997 and is headquartered in Winston-Salem, North Carolina.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Targacept is down 81.25% over the last year vs S&P 500 Total Return down 0.41%, ADVENTRX Pharmaceuticals down 78.73%, and Verastem down 6.37%.
- TRGT Total Returns
- ^SPXTR Total Returns
- ANX Total Returns
- VSTM Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TRGT related companies
Pro Strategies Featuring TRGT
Did Targacept make it into our Pro Portfolio Strategies?
TRGT Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other TRGT Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TRGT | 4.14 | -0.01 | -0.24% | 138.61M |
| TRGP | 42.53 | -1.81 | -4.08% | 1.878B |
| TRF | 12.80 | -0.39 | -2.96% | |
| TREX | 27.05 | -2.05 | -7.04% | 455.42M |
| TREE | 8.95 | -0.08 | -0.89% | 99.78M |
| TRC | 25.29 | -1.35 | -5.07% | 532.53M |
| TRAK | 25.75 | -1.55 | -5.68% | 1.145B |
| TCB | 10.99 | -0.80 | -6.79% | 1.910B |
| TCAP | 19.98 | -0.36 | -1.77% | 553.45M |
| TC | 3.44 | +0.01 | +0.29% | 576.51M |
